16:29 , Aug 18, 2017 |  BC Week In Review  |  Financial News

Drug delivery play Intec raises $50M

On Aug. 16, Intec Pharma Ltd. (Tel Aviv; NASDAQ:NTEC) raised $50 million through the sale of 10.6 million shares at $4.70 in a follow-on underwritten by Oppenheimer, Roght Capital Partners and Maxim Group. Intec expects...
22:32 , Aug 16, 2017 |  BC Extra  |  Financial News

Drug delivery play Intec raises $50M

Intec Pharma Ltd. (Tel Aviv:NTEC; NASDAQ:NTEC) jumped $0.65 (13%) to $5.50 on NASDAQ after raising $50 million through the sale of 10.6 million shares at $4.70 in a follow-on underwritten by Oppenheimer, Roth Capital Partners...
21:17 , Nov 8, 2016 |  BC Week In Review  |  Clinical News

Carbidopa/levodopa GR: Ph III amended

Intec amended the ongoing, double-blind, double-dummy, U.S. Phase III Accordance Study of oral AP-CDLD to reduce enrollment to 328 patients from 460. Intec said the amendment reflects input from "key opinion leaders and biostatisticians specializing...
07:00 , Apr 11, 2016 |  BC Week In Review  |  Clinical News

Carbidopa/levodopa GR: Phase III started

Intec began a double-blind, double-dummy, U.S. Phase III trial to compare oral AP-CDLD containing 50 mg carbidopa with 400 or 500 mg levodopa given twice or 3 times daily vs. Sinemet IR levodopa/carbidopa in about...
23:36 , Aug 4, 2015 |  BC Extra  |  Financial News

Intec raises $30.2M in U.S. listing

Intec Pharma Ltd. (Tel Aviv:INTP; NASDAQ:NTEC) held at $6 in its first day of trading on NASDAQ after it raised $30.2 million through the sale of 5 million shares at $6 in a U.S. listing...